Help us: Donate
Follow us on:
×

Menu

Back

Steve Hill

About Steve Hill

Steve serves on the LEAF Board of Directors and is the Editor in Chief, coordinating the daily news articles and social media content of the organization. He is an active journalist in the aging research and biotechnology field and has to date written over 600 articles on the topic, interviewed over 100 of the leading researchers in the field, hosted livestream events focused on aging, as well as attending various medical industry conferences. His work has been featured in H+ magazine, Psychology Today, Singularity Weblog, Standpoint Magazine, Swiss Monthly, Keep me Prime, and New Economy Magazine. Steve is one of three recipients of the 2020 H+ Innovator Award and shares this honour with Mirko Ranieri – Google AR and Dinorah Delfin – Immortalists Magazine. The H+ Innovator Award looks into our community and acknowledges ideas and projects that encourage social change, achieve scientific accomplishments, technological advances, philosophical and intellectual visions, author unique narratives, build fascinating artistic ventures, and develop products that bridge gaps and help us to achieve transhumanist goals. Steve has a background in project management and administration which has helped him to build a united team for effective fundraising and content creation, while his additional knowledge of biology and statistical data analysis allows him to carefully assess and coordinate the scientific groups involved in the project.

Campaigns Supported

Related Organizations

Articles from this author

March 02, 2021
This is part one of a two-part article where we take a look at NAD+ biology, its history, how it relates to the biology of aging, and the potential for therapeutic interventions via the so-called NAD+ precursors. What is NAD+? Nicotinamide adenine dinucleotide (NAD) is a coenzyme found in all living cells. It is a...
Bold logo
February 26, 2021
Thanks to an injection of seed round cash, a new company, Bold, joins the growing pool of organizations that are focused on wellness and disease prevention. The rising interest in wellness and healthy aging It’s no secret that the interest in digital health and wellness has risen in recent years along with the popularity of...
ChromaDex
February 24, 2021
ChromaDex has recently announced that it has agreed a securities purchase agreement for the sale of $25 million of its common stock in a private placement. The private placement was led by an international investor, with ChromaDex agreeing to sell 3,846,153 shares of its common stock at a per-share price of $6.50. ChromaDex is the...
Blood vessels
February 22, 2021
Tissue engineering company Humacyte is about to make a special purpose acquisition company (SPAC) deal in order to go public. The company is developing bioengineered Human Acellular Vessels (HAVs), which provide prosthetic vasculature to support the repair, reconstruction, and replacement of blood vessels damaged by injury or disease. What is a SPAC? A special purpose...
February 21, 2021
Join Dr. Oliver Medvedik at 12:00 Eastern, February 25th for the Journal Club. As lifespan Heroes you also have the option to join the call live and join in directly with Dr. Medvedik and the team. You can find the zoom connection info below: Time: Feb 25, 2021 12:00 PM Eastern Time (US and Canada)...
February 21, 2021
Join Dr. Oliver Medvedik at 12:00 Eastern, February 25th for the Journal Club livestreamed on our Facebook page. Researchers have discovered that mitochondria trigger cellular senescence through communication with the cell's nucleus and identified that a HDAC inhibitor, an FDA-approved drug, helped suppress the damaging effects of the condition in cells and mice. The discovery...